Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
      • Interviews
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
      • Interviews
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

News & Insights

View allAd hocDDup 11InterviewsPostersPress ReleasePublicationsScientific journalsTechnological insightsTrade journalsWebinarsWhite Papers & Application Notes

Development of recombinase-based targeted integration systems from production of exogenous proteins using transposon-mediated landing pads

PostersJuly 22, 2022

Download this poster presented at ESACT 2022 about how we developed two targeted integration systems that express high levels of recombinant protein in CHO cells…

Learn more

Flexible, Continuous Manufacturing Technologies

Trade journalsJune 29, 2022

Read the article on our continuous manufacturing technologies used in our cGMP manufacturing facility J.POD.

Learn more
Just-Evotec Webinar

EVOiR&D: an integrated discovery and development platform to deliver best-in-class biologics at Evotec and Just-Evotec Biologics

WebinarsJune 28, 2022

Watch the recorded webinar on AI-driven antibody discovery as part of Evotec’s Innovation Week held in December 2021. A week full of live sessions with…

Learn more
BPI Cover

Biologics Manufacturing Without the Big Bioreactors

Trade journalsJune 22, 2022

Read the article on our cGMP manufacturing facility J.POD in the June edition of BioProcess Int.

Learn more

AI-derived Antibodies against SARS-CoV-2 strains

PostersJune 10, 2022

Download this poster presented at the 2022 International Conference on Antiviral Research entitled AI-Derived Antibodies are novel, diverse and pharmacologically active against multiple SARS-CoV-2 strains

Learn more

Improving virus clearing studies in recombinant protein production

PostersJune 10, 2022

Download this poster presented at the 2022 ACS spring conference entitled High throughput optimization of chromatography steps for viral clearance using retrovirus-like particles (RVLPs)

Learn more
Just-Evotec Webinar

Translate your idea into product: AI-driven antibody discovery at Evotec

WebinarsJanuary 26, 2022

Watch the recorded webinar on AI-driven antibody discovery as part of Evotec’s Innovation Week held in December 2021. A week full of live sessions with…

Learn more

Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing

Press ReleaseMay 10, 2023

Just – Evotec Biologics, launched a long-term tech partnership with Sandoz for the immediate development and manufacturing of biosimilars

Learn more

Evotec Receives € 150 m Loan from European Investment Bank

Press ReleaseFebruary 10, 2023

EIB has granted Evotec an unsecured Loan facility of € 150 m to support the company’s R&D activities, equity investments and the building of the…

Learn more

Just – Evotec Biologics’ J.POD® wins CPhI Pharma Award 2022 for Manufacturing Technology and Equipment

Press ReleaseNovember 2, 2022

Just–Evotec Biologics has been awarded for its flexible cGMP biomanufacturing plant J.POD. The CPhI Award for Manufacturing Technology and Equipment honors innovation in technologies, products,…

Learn more

Just – Evotec Biologics awarded contract from U.S. Department of Defense under accelerated antibodies program

Press ReleaseSeptember 20, 2022

Just–Evotec Biologics will support the DOD with rapid, cost-efficient development of safe, efficacious anti-plague mabs. Evotec will provide pre-clinical and clinical trial services.

Learn more

Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU)

Press ReleaseSeptember 19, 2022

J.POD® Toulouse, France (EU) Brings a disruptive, flexibly scalable biologics manufacturing technology to the region. The manufacturing facility is expected to be operational in H2…

Learn more
←123456→
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.eu

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2023 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top
  • Ask an expert
  • Tweet
  • Share
  • Email
  • Scroll to top
  • Ask an expert
  • Twitter
  • Linkedin
  • Email
  • Whatsapp